Saffar Mohammed Jafar, Abedian Omid, Ajami Abolghasem, Abedian Farshideh, Mirabi Araz Mohammad, Khalilian Ali-Reza, Saffar Hana
Pediatric Infectious Diseases Ward and Thalassemia Research Center, Bouali-Cina Hospital, University of Medical Sciences, Sari, IR Iran.
Hepat Mon. 2012 May;12(5):326-32. doi: 10.5812/hepatmon.6035. Epub 2012 May 30.
To determine age-specific seroprevalence rates of hepatitis A virus (HAV) immunoglobulin G (IgG) antibody in Savadkuh district, Mazandaran province, north of Iran, as well as to compare the collected data with earlier seroprevalence studies in the region and Iran in order to draw a proper epidemiological pattern for HAV infection in the country.
This study aimed to assess an age-specific HAV seroprevalence among 1- to 30-yearold people in Savadkuh, a less developed district of Mazandaran province, north of Iran.
The study participants were 984 subjects who aged from one to 30 years and were residents of rural and urban areas of Savadkuh. They were selected using cluster sampling method and divided into five age groups: 1-2.9 (316 cases), 3-6.9 (254 cases), 7-10.9 (201 cases), 11-17.9 (115 cases), and 18-30 (98 cases). Anti-HAV antibody was measured by ELISA method. Seroprevalence rates among different age groups and their relationship to residency, educational levels of parents, water supply, and waste water disposal system was analyzed using chi-squared test.
Overall seroprevalence rate was 19.20 % with no significant difference between rural and urban residents. The seroprevalence rates increased significantly with age: from 5.7 % in age group 1-2.9 year to 34.8 % in adolescents, and to 68.4 % among young adults (P < 0.0001); regardless of significant differences in educational levels among parents of residents in two areas it did not affect seroprevalence rates. Findings of this study and reviewing other reports from the region and the country suggest an epidemiological shift towards lower rates of anti-HAV antibody seroprevalence.
It appears that anti-HAV antibody seroprevalence rate has been declining among Iranians and thereby more children would be susceptible to this infection. This would necessitate revising current strategies of preventative measures in Mazandaran and Iran.
确定伊朗北部马赞德兰省萨瓦德库赫地区甲型肝炎病毒(HAV)免疫球蛋白G(IgG)抗体的年龄特异性血清流行率,并将收集的数据与该地区和伊朗早期的血清流行率研究进行比较,以便为该国甲型肝炎病毒感染绘制合适的流行病学模式。
本研究旨在评估伊朗北部马赞德兰省欠发达地区萨瓦德库赫1至30岁人群中甲型肝炎病毒的年龄特异性血清流行率。
研究参与者为984名年龄在1至30岁之间、居住在萨瓦德库赫城乡的受试者。采用整群抽样方法进行选择,并分为五个年龄组:1至2.9岁(316例)、3至6.9岁(254例)、7至10.9岁(201例)、11至17.9岁(115例)和18至30岁(98例)。采用酶联免疫吸附测定(ELISA)法检测抗甲型肝炎病毒抗体。使用卡方检验分析不同年龄组的血清流行率及其与居住情况(城乡)、父母教育水平、供水和污水处理系统的关系。
总体血清流行率为19.20%,城乡居民之间无显著差异。血清流行率随年龄显著增加:1至2.9岁年龄组为5.7%,青少年为34.8%,年轻人为68.4%(P<0.0001);尽管两个地区居民父母的教育水平存在显著差异,但这并未影响血清流行率。本研究结果以及对该地区和该国其他报告的回顾表明,抗甲型肝炎病毒抗体血清流行率呈下降趋势。
伊朗人抗甲型肝炎病毒抗体血清流行率似乎一直在下降,因此更多儿童易感染这种疾病。这将需要修订马赞德兰省和伊朗目前的预防措施策略。